Antibiotics vs Surgery for Appendicitis in Vulnerable Populations

Phase 1, randomised, open-label trial in acute appendicitis (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Feasibility of the intervention as measured by the proportion of enrolled participants retained in this study and Feasibility of the intervention as measured by the number of complications or adverse events. Planned start Oct 2023; status: withdrawn.